Latham & Watkins has advised Thailand’s Global Renewable Synergy Company (GRSC) on its $453 million acquisition of a stake in Indian solar power company Avaada Energy.
Shardul Amarchand Mangaldas (SAM) has advised India’s Bharat Petroleum Corporation (BPCL) on its $321 million buyout of the stake held by its partner, Oman’s OQ, in their joint venture Bharat Oman Refineries (BORL).
Shardul Amarchand Mangaldas and Hogan Lovells have advised Indian e-commerce giant Flipkart on its $3.6 billion funding round led by investors such as SoftBank, which was counselled by Cooley.
Freshfields Bruckhaus Deringer, Gibson, Dunn & Crutcher, King & Wood Mallesons and DLA Piper have advised Chinese biopharma company Hutchmed on its HK$4.17 billion ($537 million) secondary listing in Hong Kong.
Linklaters and Haiwen & Partners are advising China Tourism Group Duty Free Corporation on its planned secondary listing in Hong Kong, with Freshfields Bruckhaus Deringer and Jia Yuan Law Offices advising the joint underwriters.
Sullivan & Cromwell and Fangda Partners are advising Chinese smart electric vehicle maker Xpeng on its planned dual primary listing in Hong Kong, with Freshfields Bruckhaus Deringer and JunHe advising the joint sponsors. The listing is expected to raise nearly $2 billion.
AZB & Partners has advised investment firm KKR on its $625 million acquisition of a stake in India’s Vini Cosmetics, which was counselled by Shardul Amarchand Mangaldas, with IndusLaw representing the seller Sequoia Capital.
Davis Polk & Wardwell and Global Law Office are advising Chinese bubble-tea maker Nayuki Holdings on its planned IPO in Hong Kong, with Kirkland & Ellis and Jingtian & Gongcheng advising the joint sponsors.
Wong & Partners, Baker McKenzie’s Malaysia member firm, is advising Italian insurer Assicurazioni Generali on multiple acquisitions in the Southeast Asian country totaling $312 million.
Cleary Gottlieb Steen & Hamilton and Assegaf Hamzah & Partners are advising airline Garuda Indonesia on its strategy after the flag carrier said it could not distribute coupon payments for its $500 million sukuk following a 14-day grace period.
Davis Polk & Wardwell and Global Law Office are advising medical research firm CARsgen Therapeutics on its planned IPO in Hong Kong, with Herbert Smith Freehills and Zhong Lun Law Firm advising the joint underwriters. The IPO is expected to raise up to $400 million.
Wilson Sonsini Goodrich & Rosati and Han Kun Law Offices have advised Chinese dental brace maker Angelalign Technology on its $375 million IPO on the Hong Kong Stock Exchange, with Clifford Chance and Tian Yuan Law Firm advising the joint underwriters.